172 related articles for article (PubMed ID: 12602354)
1. Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.
Kazaks A; Lachmann S; Koletzki D; Petrovskis I; Dislers A; Ose V; Skrastina D; Gelderblom HR; Lundkvist A; Meisel H; Borisova G; Krüger DH; Pumpens P; Ulrich R
Intervirology; 2002; 45(4-6):340-9. PubMed ID: 12602354
[TBL] [Abstract][Full Text] [Related]
2. New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge.
Ulrich R; Koletzki D; Lachmann S; Lundkvist A; Zankl A; Kazaks A; Kurth A; Gelderblom HR; Borisova G; Meisel H; Krüger DH
J Biotechnol; 1999 Aug; 73(2-3):141-53. PubMed ID: 10486924
[TBL] [Abstract][Full Text] [Related]
3. HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein.
Koletzki D; Biel SS; Meisel H; Nugel E; Gelderblom HR; Krüger DH; Ulrich R
Biol Chem; 1999 Mar; 380(3):325-33. PubMed ID: 10223335
[TBL] [Abstract][Full Text] [Related]
4. Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles.
Koletzki D; Lundkvist A; Sjölander KB; Gelderblom HR; Niedrig M; Meisel H; Krüger DH; Ulrich R
Virology; 2000 Oct; 276(2):364-75. PubMed ID: 11040127
[TBL] [Abstract][Full Text] [Related]
5. Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice.
Gedvilaite A; Zvirbliene A; Staniulis J; Sasnauskas K; Krüger DH; Ulrich R
Viral Immunol; 2004; 17(1):51-68. PubMed ID: 15018662
[TBL] [Abstract][Full Text] [Related]
6. Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.
Sominskaya I; Skrastina D; Dislers A; Vasiljev D; Mihailova M; Ose V; Dreilina D; Pumpens P
Clin Vaccine Immunol; 2010 Jun; 17(6):1027-33. PubMed ID: 20410327
[TBL] [Abstract][Full Text] [Related]
7. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
8. Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments.
Koletzki D; Zankl A; Gelderblom HR; Meisel H; Dislers A; Borisova G; Pumpens P; Krüger DH; Ulrich R
J Gen Virol; 1997 Aug; 78 ( Pt 8)():2049-53. PubMed ID: 9267006
[TBL] [Abstract][Full Text] [Related]
9. An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice.
Geldmacher A; Skrastina D; Petrovskis I; Borisova G; Berriman JA; Roseman AM; Crowther RA; Fischer J; Musema S; Gelderblom HR; Lundkvist A; Renhofa R; Ose V; Krüger DH; Pumpens P; Ulrich R
Virology; 2004 May; 323(1):108-19. PubMed ID: 15165823
[TBL] [Abstract][Full Text] [Related]
10. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
[TBL] [Abstract][Full Text] [Related]
11. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.
Pumpens P; Razanskas R; Pushko P; Renhof R; Gusars I; Skrastina D; Ose V; Borisova G; Sominskaya I; Petrovskis I; Jansons J; Sasnauskas K
Intervirology; 2002; 45(1):24-32. PubMed ID: 11937768
[TBL] [Abstract][Full Text] [Related]
13. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
Schödel F; Peterson D; Hughes J; Milich DR
Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
[TBL] [Abstract][Full Text] [Related]
14. A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles.
Blokhina EA; Kuprianov VV; Stepanova LA; Tsybalova LM; Kiselev OI; Ravin NV; Skryabin KG
Virology; 2013 Jan; 435(2):293-300. PubMed ID: 23062739
[TBL] [Abstract][Full Text] [Related]
15. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
[TBL] [Abstract][Full Text] [Related]
17. Construction and immunological evaluation of truncated hepatitis B core particles carrying HBsAg amino acids 119-152 in the major immunodominant region (MIR).
Su Q; Yi Y; Guo M; Qiu F; Jia Z; Lu X; Meng Q; Bi S
Biochem Biophys Res Commun; 2013 Sep; 439(1):84-9. PubMed ID: 23969156
[TBL] [Abstract][Full Text] [Related]
18. Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model.
Ulrich R; Lundkvist A; Meisel H; Koletzki D; Sjölander KB; Gelderblom HR; Borisova G; Schnitzler P; Darai G; Krüger DH
Vaccine; 1998; 16(2-3):272-80. PubMed ID: 9607042
[TBL] [Abstract][Full Text] [Related]
19. Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope.
Lachmann S; Meisel H; Muselmann C; Koletzki D; Gelderblom HR; Borisova G; Krüger DH; Pumpens P; Ulrich R
Intervirology; 1999; 42(1):51-6. PubMed ID: 10393504
[TBL] [Abstract][Full Text] [Related]
20. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
